Steven Schutzer from Rutgers New Jersey Medical School is leading a team assessing new vaccine strategies for Lyme disease, including a hybrid approach that can deliver a one-two punch to the microbe that causes the disease and its tick carrier. Learn more.
Recent Posts
- Anonymous Distribution of Naloxone via Vending Machines Raises Uptake by Ex-Prisoners, Rutgers Researchers Find.
- New NJACTS Publication
- Rutgers Researchers Help Redefine Core Microbiome, Opening New Chapter in Precision Health.
- Interested in Accessing Clinical Data?
- Rutgers Health has big plans to spend $47.5M on new ideas at gleaming new Helix tower.
Categories
- Community (2,072)
- Covid (979)
- CTO Events (5)
- News (2,633)
- Pilots (20)